Cargando…
Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs
Affinity maturation is often a necessary step for the development of potent therapeutic molecules. Many different diversification strategies have been used for antibody affinity maturation, including error-prone PCR, chain shuffling, and targeted complementary-determining region (CDR) mutation. Alth...
Autores principales: | Teixeira, Andre A. R., D’Angelo, Sara, Erasmus, M. Frank, Leal-Lopes, Camila, Ferrara, Fortunato, Spector, Laura P., Naranjo, Leslie, Molina, Esteban, Max, Tamara, DeAguero, Ashley, Perea, Katherine, Stewart, Shaun, Buonpane, Rebecca A., Nastri, Horacio G., Bradbury, Andrew R. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467613/ https://www.ncbi.nlm.nih.gov/pubmed/36068722 http://dx.doi.org/10.1080/19420862.2022.2115200 |
Ejemplares similares
-
A single donor is sufficient to produce a highly functional in vitro antibody library
por: Erasmus, M. Frank, et al.
Publicado: (2021) -
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries
por: Azevedo Reis Teixeira, Andre, et al.
Publicado: (2021) -
International Advisory Committee Final Statement on the FCC CDRs
por: Dissertori, Guenther
Publicado: (2019) -
Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding
por: D’Angelo, Sara, et al.
Publicado: (2018) -
Pandemic’s silver lining
por: Ferrara, Fortunato, et al.
Publicado: (2022)